Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


In Brief: State and foreign government officials

This article was originally published in The Gray Sheet

Executive Summary

State and foreign government officials: FDA final rule on intergovernmental communication in Dec. 8 Federal Register permits FDA "to receive and to disclose nonpublic safety, effectiveness or quality information concerning FDA-regulated products to state government officials and to receive or to disclose draft proposed rules and other nonpublic, predecisional documents concerning regulatory requirements or activities to state or foreign government officials." The rule extends a 1993 final rule concerning disclosure of confidential information to foreign governments to apply to states as well...



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts